APA
Theunissen T. E. J., Nguyen M., Kamps R., Hendrickx A. T., Sallevelt S. C. E. H., Gottschalk R. W. H., Calis C. M., Stassen A. P. M., de Koning B., Mulder-Den Hartog E. N. M., Schoonderwoerd K., Fuchs S. A., Hilhorst-Hofstee Y., de Visser M., Vanoevelen J., Szklarczyk R., Gerards M., de Coo I. F. M., Hellebrekers D. M. E. I. & Smeets H. J. M. (2018). Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. : Frontiers in genetics.
Chicago
Theunissen Tom E J, Nguyen Minh, Kamps Rick, Hendrickx Alexandra T, Sallevelt Suzanne C E H, Gottschalk Ralph W H, Calis Chantal M, Stassen Alphons P M, de Koning Bart, Mulder-Den Hartog Elvira N M, Schoonderwoerd Kees, Fuchs Sabine A, Hilhorst-Hofstee Yvonne, de Visser Marianne, Vanoevelen Jo, Szklarczyk Radek, Gerards Mike, de Coo Irenaeus F M, Hellebrekers Debby M E I and Smeets Hubert J M. 2018. Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. : Frontiers in genetics.
Harvard
Theunissen T. E. J., Nguyen M., Kamps R., Hendrickx A. T., Sallevelt S. C. E. H., Gottschalk R. W. H., Calis C. M., Stassen A. P. M., de Koning B., Mulder-Den Hartog E. N. M., Schoonderwoerd K., Fuchs S. A., Hilhorst-Hofstee Y., de Visser M., Vanoevelen J., Szklarczyk R., Gerards M., de Coo I. F. M., Hellebrekers D. M. E. I. and Smeets H. J. M. (2018). Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. : Frontiers in genetics.
MLA
Theunissen Tom E J, Nguyen Minh, Kamps Rick, Hendrickx Alexandra T, Sallevelt Suzanne C E H, Gottschalk Ralph W H, Calis Chantal M, Stassen Alphons P M, de Koning Bart, Mulder-Den Hartog Elvira N M, Schoonderwoerd Kees, Fuchs Sabine A, Hilhorst-Hofstee Yvonne, de Visser Marianne, Vanoevelen Jo, Szklarczyk Radek, Gerards Mike, de Coo Irenaeus F M, Hellebrekers Debby M E I and Smeets Hubert J M. Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. : Frontiers in genetics. 2018.